BioCrude Technologies USA, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
BioCrude Technologies USA, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • BioCrude Technologies USA, Inc. Return On Equity for the quarter ending September 30, 2024 was 104 %, a 16.3% decline year-over-year.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2023 was 118 %, a 16.6% increase from 2022.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2022 was 102 %, a 78.5% decline from 2021.
  • BioCrude Technologies USA, Inc. annual Return On Equity for 2021 was 472 %, a 328% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 118 +16.8 +16.6% Jan 1, 2023 Dec 31, 2023
2022 102 -370 -78.5% Jan 1, 2022 Dec 31, 2022
2021 472 +362 +328% Jan 1, 2021 Dec 31, 2021
2020 110 +11.3 +11.4% Jan 1, 2020 Dec 31, 2020
2019 98.9 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.